Remifentanil versus Fentanyl for Assisted Reproductive Technologies: A Randomized Clinical Trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201009283468N3

Enrollment

145

Registered

2011-02-28

Start date

2008-02-29

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Supervision of pregnancy with history of infertility

Interventions

Intervention 1: group A: 1 microgram/kilogram remifentanil before induction of anesthesia. Intervention 2: group B: 2 microgram/kilogram fentanyl before induction of anesthesia.

Treatment - Drugs

group A: 1 microgram/kilogram remifentanil before induction of anesthesia

group B: 2 microgram/kilogram fentanyl before induction of anesthesia

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: without any concurrent disease and candidate for general anesthesia for microinjection. Exclusion criteria: duration of anesthesia over than general.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Chemical pregnancy. Timepoint: Treatment Cycle Length. Method of measurement: BHCG.	—

Secondary

Measure	Time frame
Clinical pregnancy. Timepoint: treatment cycle length. Method of measurement: ultrasonography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Reza Haji Esmaeili

Shahid Sadoughi University of medical sciences and health services

hajiesmaeili@ssu.ac.ir+98 35 1625 8722

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026